Inaxaplin Reduces Proteinuria in FSGS With APOL1 Variants
Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria.
Study findings suggest targeted inhibition of APOL1 function can reduce proteinuria.
No difference in mortality observed for Black and White men for nonelective surgeries, but mortality lower for Black and White women
Multiancestry polygenic risk score can stratify prostate cancer risk and differentiate risk for aggressive disease
Odds remain increased after adjustment for social determinants of health, health factors, modifiable health behavior
Among men with intermediate- and high-risk disease, Black men had significant 22% and 37% lower odds of receiving definitive treatment, respectively, compared with White men, a study found.
New study corroborates findings from a prior study of men receiving care in the Veterans Health Administration system.
Black patients without high-risk APOL1 alleles did not have higher risks for kidney failure.
Lower odds ratios seen for insulin pump use for Hispanic, Black, other race versus White; with lower education, lower household income
Prostate cancer has one of the largest racial disparities in outcomes between Black and White patients, according to investigators.
The OPTN policy revision may increase some Black kidney candidates’ total waiting time, which is a major factor in their transplant priority for organ offers.